CloudMD Software & Services (OTCMKTS:DOCRF) and Novita Healthcare (ASX:NHL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability and valuation.
Profitability
This table compares CloudMD Software & Services and Novita Healthcare's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
CloudMD Software & Services | N/A | N/A | N/A |
Novita Healthcare | N/A | N/A | N/A |
Valuation & Earnings
This table compares CloudMD Software & Services and Novita Healthcare's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
CloudMD Software & Services | N/A | N/A | N/A | N/A | N/A |
Novita Healthcare | N/A | N/A | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for CloudMD Software & Services and Novita Healthcare, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
CloudMD Software & Services | 0 | 0 | 2 | 0 | 3.00 |
Novita Healthcare | 0 | 0 | 0 | 0 | N/A |
CloudMD Software & Services currently has a consensus price target of $3.3750, suggesting a potential upside of 117.74%.
Summary
CloudMD Software & Services beats Novita Healthcare on 1 of the 1 factors compared between the two stocks.